These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nitazoxanide: an important advance in anti-parasitic therapy. White AC Am J Trop Med Hyg; 2003 Apr; 68(4):382-3. PubMed ID: 12875283 [No Abstract] [Full Text] [Related]
4. Nitazoxanide for treatment of intestinal parasites in children. Ochoa TJ; White AC Pediatr Infect Dis J; 2005 Jul; 24(7):641-2. PubMed ID: 15999008 [No Abstract] [Full Text] [Related]
6. Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine. Guffanti M; Gaiera G; Bossolasco S; Ceserani N; Ratti D; Cinque P; Salmaso F; Gianotti N; Lazzarin A Am J Trop Med Hyg; 2008 Nov; 79(5):715-8. PubMed ID: 18981510 [TBL] [Abstract][Full Text] [Related]
7. Development of miltefosine for the leishmaniases. Berman JD Mini Rev Med Chem; 2006 Feb; 6(2):145-51. PubMed ID: 16472183 [TBL] [Abstract][Full Text] [Related]
8. Nitazoxanide. Parashar A; Arya R Indian Pediatr; 2005 Nov; 42(11):1161-5. PubMed ID: 16340060 [No Abstract] [Full Text] [Related]
9. Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus). Gargala G; François A; Favennec L; Rossignol JF Antimicrob Agents Chemother; 2013 Jun; 57(6):2821-3. PubMed ID: 23478972 [TBL] [Abstract][Full Text] [Related]
10. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. Dorlo TP; Balasegaram M; Beijnen JH; de Vries PJ J Antimicrob Chemother; 2012 Nov; 67(11):2576-97. PubMed ID: 22833634 [TBL] [Abstract][Full Text] [Related]
12. Repurposing miltefosine for the treatment of immune-mediated disease? Verhaar AP; Wildenberg ME; Peppelenbosch MP; Hommes DW; van den Brink GR J Pharmacol Exp Ther; 2014 Aug; 350(2):189-95. PubMed ID: 24833702 [TBL] [Abstract][Full Text] [Related]
13. Nitazoxanide: a new broad spectrum antiparasitic agent. White CA Expert Rev Anti Infect Ther; 2004 Feb; 2(1):43-9. PubMed ID: 15482170 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Diaz E; Mondragon J; Ramirez E; Bernal R Am J Trop Med Hyg; 2003 Apr; 68(4):384-5. PubMed ID: 12875284 [TBL] [Abstract][Full Text] [Related]
15. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Anderson VR; Curran MP Drugs; 2007; 67(13):1947-67. PubMed ID: 17722965 [TBL] [Abstract][Full Text] [Related]
16. Nitazoxanide: a new thiazolide antiparasitic agent. Fox LM; Saravolatz LD Clin Infect Dis; 2005 Apr; 40(8):1173-80. PubMed ID: 15791519 [TBL] [Abstract][Full Text] [Related]
17. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Davila-Gutierrez CE; Vasquez C; Trujillo-Hernandez B; Huerta M Am J Trop Med Hyg; 2002 Mar; 66(3):251-4. PubMed ID: 12139216 [TBL] [Abstract][Full Text] [Related]
18. Miltefosine: issues to be addressed in the future. Berman J; Bryceson AD; Croft S; Engel J; Gutteridge W; Karbwang J; Sindermann H; Soto J; Sundar S; Urbina JA Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S41-4. PubMed ID: 16750231 [TBL] [Abstract][Full Text] [Related]
19. [New drugs for the treatment of human parasitic protozoa]. Dupouy-Camet J Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692 [TBL] [Abstract][Full Text] [Related]